Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 108.58M P/E - EPS this Y 6.40% Ern Qtrly Grth -
Income -50.39M Forward P/E -1.77 EPS next Y 13.60% 50D Avg Chg -7.00%
Sales 353k PEG -0.14 EPS past 5Y - 200D Avg Chg -9.00%
Dividend N/A Price/Book 0.97 EPS next 5Y 13.00% 52W High Chg -53.00%
Recommedations 2.00 Quick Ratio 6.13 Shares Outstanding 67.94M 52W Low Chg 29.00%
Insider Own 2.62% ROA -31.72% Shares Float 60.12M Beta 1.23
Inst Own 61.91% ROE -62.31% Shares Shorted/Prior 383.05K/289.27K Price 2.00
Gross Margin - Profit Margin - Avg. Volume 498,080 Target Price 22.60
Oper. Margin -15,557.79% Earnings Date Mar 14 Volume 336,694 Change 1.52%
About aTyr Pharma, Inc.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

aTyr Pharma, Inc. News
05/06/24 aTyr Pharma to Present at Upcoming Investor Conferences
05/02/24 aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
04/21/24 aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k
04/01/24 aTyr Pharma to Participate in April Investor Conferences
03/26/24 3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
03/16/24 aTyr Pharma Full Year 2023 Earnings: Revenues Disappoint
03/15/24 aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript
03/15/24 Q4 2023 aTyr Pharma Inc Earnings Call
03/15/24 aTyr Pharma Inc (LIFE) Reports Full Year 2023 Financial Results and Corporate Progress
03/14/24 aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
02/28/24 aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
02/23/24 We Think aTyr Pharma (NASDAQ:LIFE) Can Afford To Drive Business Growth
02/21/24 aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
02/03/24 After losing 23% in the past year, aTyr Pharma, Inc. (NASDAQ:LIFE) institutional owners must be relieved by the recent gain
01/29/24 aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
01/18/24 aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
11/13/23 aTyr Pharma's Market Cap Drops To US$66m Leaving Insiders With Losses
11/13/23 aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
11/09/23 aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
11/01/23 aTyr Pharma to Present at November Investor Conferences
LIFE Chatroom

User Image deirishpiser Posted - 13 hours ago

$LIFE lol typical with this pos

User Image Stokwits Posted - 13 hours ago

$LIFE Good Day everyone! Nice to see some positive action here compared to my ALLR position.

User Image RETAlerts Posted - 15 hours ago

$LIFE at 1.732 has shown some initial momentum, and is 5% up since landing on our scanner, let's see if any overhead resistance levels get broken with conviction. (15 minute delay)

User Image jacksparo Posted - 15 hours ago

$LIFE Long term since last year still holding needs another 150% to exit!

User Image Jscott76 Posted - 15 hours ago

$LIFE Wild Action!!

User Image RallyRaider Posted - 18 hours ago

$LIFE holding up very nicely. 2$ soon

User Image neverbeenwrong Posted - 3 days ago

$LIFE Cash position strong, fully funded through approval. Enrollment in phase 3 complete in less than 2 months. Stock price lagging good news. Hmmm.

User Image epsguid Posted - 4 days ago

$LIFE reported a loss of $0.23, consensus was ($0.24) via @eWhispers #epsbeat http://eps.sh/d/life

User Image Stock_Titan Posted - 4 days ago

$LIFE aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update https://www.stocktitan.net/news/LIFE/a-tyr-pharma-announces-first-quarter-2024-results-and-provides-bzavp5ax338q.html

User Image 45IQ Posted - 4 days ago

$LIFE Corporate update late next week, let's see how enrollment is looking. Looking forward to analyst questions on EAP and Q1 25 topline date reaffirmations.

User Image Jscott76 Posted - 5 days ago

$LIFE easy money under 1.60. EAP...

User Image Southski Posted - 5 days ago

$LIFE DONT SCREW THIS UP JPOW

User Image Will2ride1 Posted - 5 days ago

$LIFE buy time

User Image iBoughtTheWrongTicker Posted - 04/30/24

$LIFE waiting patiently….

User Image 45IQ Posted - 04/29/24

$LIFE Huge block purchase

User Image traderXO Posted - 04/27/24

$LIFE I did my homework and added to my portfolio for long hold

User Image 45IQ Posted - 04/26/24

@Jscott76 $LIFE Just picked up another 2k shares at 1.58,

User Image Jscott76 Posted - 04/26/24

$LIFE thoughts at these levels? I know this is support.

User Image Southski Posted - 04/25/24

$LIFE

User Image iBoughtTheWrongTicker Posted - 04/25/24

$LIFE big bounce

User Image soll Posted - 04/23/24

$LIFE what is the estimated date for their cash runway?

User Image jacksparo Posted - 04/22/24

$LIFE Holding some of this still 📈✅!

User Image 45IQ Posted - 04/19/24

$LIFE Added at 1.62, 16k shares and accumulating

User Image CliffordCapital Posted - 04/19/24

$LIFE when is pdufa here lads?

User Image neverbeenwrong Posted - 04/19/24

$LIFE Fully funded through FDA approval. No need to raise capital. What a diamond in the rough this stock is. $XBI

User Image 45IQ Posted - 04/17/24

$LIFE Do we see 1.50 today? Let's get another big dip in, more dry powder incoming

User Image neverbeenwrong Posted - 04/15/24

$LIFE Cash rich. Fully funded through approval. Great long term stock.

User Image Jscott76 Posted - 04/15/24

$LIFE added at 1.69..

User Image deirishpiser Posted - 04/15/24

$LIFE same people saying the same things....and still a crappy sub 100m market cap. this thing is dead in the water

User Image Will2ride1 Posted - 04/14/24

$LIFE ok...time to take some

Analyst Ratings
HC Wainwright & Co. Buy May 3, 24
RBC Capital Outperform Mar 15, 24
HC Wainwright & Co. Buy Mar 15, 24
HC Wainwright & Co. Buy Feb 21, 24
HC Wainwright & Co. Buy Sep 21, 23
HC Wainwright & Co. Buy Sep 14, 23
HC Wainwright & Co. Buy Aug 10, 23
Piper Sandler Overweight Jul 21, 23
Oppenheimer Perform Jul 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Broadfoot Jill Marie Chief Financial Offi.. Chief Financial Officer Feb 05 Sell 1.69 1,590 2,687 20,821 02/06/24
SCHIMMEL PAUL Director Director May 10 Buy 2.25 200,000 450,000 313,023 05/11/23
Broadfoot Jill Marie Chief Financial Offi.. Chief Financial Officer Feb 03 Sell 2.36 1,566 3,696 15,460 02/06/23
Shukla Sanjay President and CEO President and CEO Nov 21 Buy 2.1405 10,000 21,405 50,798 11/21/22
Broadfoot Jill Marie Chief Financial Offi.. Chief Financial Officer Jan 13 Buy 6.75 1,923 12,980 12,112 01/18/22
Shukla Sanjay President and CEO President and CEO Jan 07 Buy 6.7613 5,000 33,806 25,798 01/10/22